Kaleidos SCS was established in 2005 in Bergamo (north of Italy) to advance biomedical research in the fields of genetic rare diseases and mental conditions, as well as to improve the quality of life of affected people and their caregivers.
Kaleidos is an accredited facility for research, we focus on the following areas:
Peer-reviewed publications and other acknowledgements are the measure of our scientific advancement and research productivity.
A number of collaborators support Kaleidos, such as clinicians (MDs, nurses, and psychologists), experts on Privacy regulations, and project and case managers. As part of Kaleidos' expertise, specific patient-centric solutions are also developed.
Kaleidos is also devoted to the so-called “digital healthcare revolution” and is focused on developing e-Health solutions that may have the potential to revolutionize the management of the health system and improve the effectiveness of diagnosis, therapies and follow-up. Indeed, digital health solutions are emerging as key technologies to increase the efficiency and effectiveness of the healthcare industry: for such reason, we recognize e-Health as a pivotal model for clinical services and decision support in the context of optimizing the delivery of health services.
Therefore, Kaleidos has developed digital health platforms, such as software-based on medical devices, machine learning technologies and tools based on artificial intelligence.